Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 30 for “"Poor responders"”.
-
Interventions for poor responders undergoing in vitro fertilisation treatment.
… interventions proposed for the management of poor responders undergoing IVF treatment. I began by performing a systematic review and meta-analysis to identify the ideal controlled ovarian hyperstimulation (COH) regimen for women with poor ovarian response undergoing IVF. The systematic review …
-
Συσχέτιση των γυναικών που υποβάλλονται σε πρωτόκολλο εξωσωματικής γονιμοποίησης με την ύπαρξη πολυμορφισμών στο γονίδιο FOXO3A και τον αριθμό επαναλαμβανόμενων αλληλουχιών (ΤΑ)n στο γονίδιο του ESR 1.
… μάρτυρες και γυναίκες που χαρακτηρίζονται ως poor responders . Ο ένας από τους δύο πολυμορφισμούς του FOXO3A (3A .7) βρέθηκε σε ποσοστό που προσεγγίζει το 50% σε γυναίκες poor responders εν αντιθέσει με τον δεύτερο προς μελέτη πολυμορφισμό (3Α .6 ) που δεν υπήρχε σε καμία από τις δύο ομάδες …
-
Ο ρόλος της διαδερμικής χορήγησης τεστοστερόνης στη διέγερση των ωοθηκών σε γυναίκες με πτωχή ωοθηκική απάντηση που υποβάλλονται σε εξωσωματική γονιμοποίηση
Poor ovarian response remains one of the most challenging areas in reproductive medicine. Over the years, various stimulation protocols have been proposed for the management of poor responders, with controversial, however, results. Recently, it has been suggested that the accumulation of androgens …
-
Assisted reproductive medicine: Systematic reviews and randomized controlled trials
… develop a novel ovarian stimulation protocol for poor responders. We used the lessons learned from our failed RCT and another systematic review to design and conduct a feasibility randomized controlled trial on the use of aromatase inhibitors to improve pregnancy outcomes for in-vitro …
-
Glucocorticoid resistance in childhood B-Cell precursor acute lymphoblastic leukaemia
… is highly prognostic of outcome, with poor responders having significantly inferior survival rates. However the mechanisms of glucocorticoid resistance are poorly understood, and identification of novel agents to reverse resistance could improve the outcomes for this high-risk group of …
-
PHENOTYPIC AND CHEMOTHERAPY RESPONSE PROFILING OF P53 WILD-TYPE AND MUTANT HUMAN BREAST CANCER CELL LINES
… marker of response may spare predicted ‘poor responders’ from the toxicity. Previously, we demonstrated a gene expression signature that predicts chemotherapy resistance which is linked to TP53 integrity. Further investigation showed that p53 signatures predict response in only ER+ …
-
Integrated pathways associated with metastasis and chemoresistance in canine osteosarcoma
… Gene expression profiling of canine tumors from poor responders compared to tumors from good responders implicated pathways critical to normal bone development including hedgehog and Wnt/β-catenin. During bone development, there is significant crosstalk between these pathways and the Notch …
-
The Notch Target Hes4 Promotes Osteosarcoma Tumor Growth and Metastasis By Inhibiting Osteogenic Differentiation, and Has Potential As A Prognostic Biomarker For Newly Diagnosed Patients With High Grade Osteosarcoma.
… for the stratification of patients into good or poor responders to chemotherapy at diagnosis. We also aim to understand the biology of these markers in OS pathogenesis. Because the development of OS is caused by genetic disruptions of osteogenic differentiation, we sought to identify pathways …
-
The impact of ovarian response on cumulative live birth rates
… normal (10-15) versus suboptimal (4-9 oocytes) responders The drop in fresh live birth rates in high responders could be attributed to the progressive increase in “freeze all” rates due to risk of OHSS. Suboptimal responders (4-9 oocytes retrieved) appear to form a distinct ovarian response …
-
Συσχέτιση των βιολογικών και κλινικών χαρακτηριστικών των πολυμορφισμών Asn/Ser, Asn/Asn, Ser/Ser του γονιδίου του υποδοχέα FSH καθώς και των πολυμορφισμών PvuII και RsaI των γονιδίων ESR1 και ESR2 των οιστρογονικών υποδοχέων ERα και ERβ στην εξωσωματική γονιμοποίηση
… ESR2 genotype patterns may partially explain the poor response to FSH. These polymorphisms seem to play a great part in determining the ovarian response in controlled ovarian stimulation during assisted reproduction techniques, considering women with normal ovarian function. These genetic …
-
Novel TMS and EEG markers of diagnosis and treatment response in epilepsy
… drug-naïve patients, distinguishing good responders from those who become intractable. I hypothesised that these markers should also be present in long-term treatment resistant epilepsy, allowing outcome prediction in patients commencing new medications. A central hypothesis in this thesis …
-
Functional gene trap mutagenesis to identify molecular mechanisms of poor initial treatment response in paediatric acute lymphoblastic leukaemia
… Leukaemia (ALL) and patients with a poor prednisone response have a higher risk of relapse when treated with conventional therapy. Approximately 5-10% of patients are classified as prednisone poor responders, and are more often resistant to other chemotherapeutic drugs and likely to …
-
The relationship between T and B cell hepatitis B virus vaccine-specific responses in a cohort of healthy infants
… 10 IU/l secreted lower levels of TNF-α. Many poor responders, as defined by their anti-HBs titers, demonstrated evidence of T cell memory either by HBsAg-specific proliferation, intracellular cytokine production, or cytokine secretion—indicating that an alternative or additional immunological …
-
EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS
… (PD) response to ASA. It has been suggested that poor responsiveness is due to increased platelet production and a bis in die (bid) administration should be preferred. Aim of this study was to investigate further the potential mechanism(s) of poor responsiveness to ASA in ETs. Methods. We enrolled …
-
Understanding the response to pre-operative therapies in colorectal cancer through phenotypic and Raman spectroscopic analysis
… response to pre-operative RT into good and poor with approximately 86 % accuracy, as determined using five-fold cross-validation. Further analysis of the spectra showed the Raman signature of good responders demonstrated increased protein contributions, whereas poor responders showed …
-
Predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with primary radiation therapy
… a reliable imaging biomarker, which can identify poor or good responders, that can be used to allow appropriate adaptive radiotherapy strategies including de-escalation for excellent-responders, intensification for poor-responders and avoidance of toxic treatments to non-responders. Aims: To …
-
Η σχέση των ορμονικών και βιολογικών παραμέτρων κατά τη χρησιμοποίηση διαφορετικών πρωτοκόλλων πολλαπλής ωοθηλακιορρηξίας στην υποβοηθούμενη αναπαραγωγή
… polycystic ovarian syndrome (PCOS) and poor ovarian reserve. We also intended to assess whether oestradiol administration improved ovulation induction parameters in poor responders and whether the use of methylprednisolone improved success rates in women with PCOS. We also wanted to …
-
Kombinationseffekte von TRAIL und Retinoiden an Zellkulturmodellen des Mammakarzinoms und des Osteosarkoms
… Da sich die Prognose der sogenannten poor responders sowie des metastasierten Osteosarkoms als besonders ungünstig erweist, ist die Etablierung weiterer wirksamer und tumorselektiver Therapieansätze auch für diese Entität von klinischer Relevanz. Für rhTRAIL, einen Vertreter der …
-
Hydroxyapatite – A trojan horse in the delivery of apatite-binding cytostatics in bone cancer
… being used for more than 30 years, the number of poor responders is increasing. Although new treatments have been explored since then, no improved tumor eradication effect have been found. In the present thesis, we have developed a new treatment method for osteosarcoma, using hydroxyapatite (HA) …
-
Η εκτίμηση της επίδρασης της ενδοφθάλμιας χρήσης της ranibizumab στην αρτηριακή υπέρταση και στην αρτηριακή σκληρία σε ασθενείς με ηλικιακή εκφύλιση ωχράς κηλίδας
… P<0.05). PWV decreased significantly in good responders (according to clinical criteria and fundus findings, P=0.004), whereas it increased numerically in poor responders (P=0.21) over the study period. In responders, hsIL-6 decreased after the first injection and remained decreased 1 month …
Page 1 of 2